Amylyx Pharmaceuticals, Inc. (AMLX)

Amylyx Pharmaceuticals Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019
Period Ending	Sep 30, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Cash & Equivalents	71.84	170.2	62.53	50.19	12.88	3.07
Short-Term Investments	162.56	201.16	284.42	45.93	-	-
Cash & Short-Term Investments	234.4	371.36	346.95	96.12	12.88	3.07
Cash Growth	-33.98%	7.04%	260.96%	646.43%	320.13%	-
Accounts Receivable	1.73	40.05	15.31	-	-	-
Other Receivables	-	0.5	0.5	-	-	-
Receivables	1.73	40.55	15.81	-	-	-
Inventory	-	38.32	9.77	-	-	-
Prepaid Expenses	9.14	14.43	9.61	5.39	0.76	0.11
Restricted Cash	-	-	-	-	-	0.03
Other Current Assets	-	-	-	3.44	-	-
Total Current Assets	245.26	464.67	382.13	104.95	13.64	3.2
Property, Plant & Equipment	3.53	6.41	8.14	0.47	0.15	-
Other Long-Term Assets	1.92	46.38	1.19	0.19	0.31	0.02
Total Assets	250.71	517.45	391.45	105.61	14.1	3.22
Accounts Payable	1.49	22.06	6.26	4.37	3.61	2.2
Accrued Expenses	50.46	57.72	38.31	13.02	3.71	2.33
Current Portion of Leases	1.97	2.26	2.04	-	-	-
Total Current Liabilities	53.92	82.04	46.61	17.4	7.33	4.53
Long-Term Debt	-	-	-	-	1.43	14.93
Long-Term Leases	0.6	1.98	4.24	-	-	-
Other Long-Term Liabilities	-	-	-	0.04	0.02	1.44
Total Liabilities	54.51	84.02	50.85	17.43	8.77	20.9
Common Stock	0.01	0.01	0.01	0	0	0
Additional Paid-In Capital	764.7	738.18	694.91	4.67	1.19	0.28
Retained Earnings	-569.15	-304.95	-354.22	-155.85	-67.91	-25.63
Comprehensive Income & Other	0.64	0.2	-0.09	0.01	-	-
Total Common Equity	196.2	433.43	340.61	-151.17	-66.73	-25.36
Shareholders' Equity	196.2	433.43	340.61	88.18	5.34	-17.68
Total Liabilities & Equity	250.71	517.45	391.45	105.61	14.1	3.22
Total Debt	2.57	4.24	6.28	-	1.43	14.93
Net Cash (Debt)	231.83	367.13	340.67	96.12	11.45	-11.87
Net Cash Growth	-33.82%	7.77%	254.43%	739.31%	-	-
Net Cash Per Share	3.42	5.25	5.82	14.59	1.88	-2.01
Filing Date Shares Outstanding	68.55	67.78	66.72	57.86	6.43	5.89
Total Common Shares Outstanding	68.55	66.51	66.51	7.02	5.99	5.89
Working Capital	191.35	382.62	335.52	87.56	6.31	-1.33
Book Value Per Share	2.86	6.52	5.12	-21.53	-11.13	-4.31
Tangible Book Value	196.2	433.43	340.61	-151.17	-66.73	-25.36
Tangible Book Value Per Share	2.86	6.52	5.12	-21.53	-11.13	-4.31
Machinery	-	3.55	2.17	0.34	0.05	-
Construction In Progress	-	0.59	0.8	0.14	0.06	-
Leasehold Improvements	-	0.18	0.18	0.05	0.04	-

Source: S&P Capital IQ. Standard template. Financial Sources.